ReadYourDNA

Provera

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Provera

What it is

Medroxyprogesterone acetate is a progestin, a synthetic form of progesterone. As a three-monthly injection (Depo-Provera) it is a widely used contraceptive; as tablets (Provera) it treats irregular or heavy periods and protects the womb lining during menopausal oestrogen therapy; at high doses it has been used for some cancers.

How genes come into it

Medroxyprogesterone is broken down mainly by CYP3A4. The gene studies listing it looked at ESR1 and VDR for bone effects with menopausal hormone therapy, and at CYP2B6 and NAT2, partly in women also taking HIV medicines such as efavirenz, which speed up its breakdown. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Provera. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

ESR1 rs9340799: Level 3. Efficacy. 1.

VDR rs1544410: Level 3. Efficacy. 1.

Metabolism (2 findings)

Studies of how quickly the body processes this medication.

CYP2B6 CYP2B6 poor metabolizer: CYP2B6 poor metabolizer is not associated with metabolism of medroxyprogesterone in women with HIV Infections and Tuberculosis as compared to CYP2B6 normal metabolizer.

NAT2 NAT2 slow acetylator: NAT2 slow acetylator is not associated with metabolism of medroxyprogesterone in women with HIV Infections and Tuberculosis as compared to NAT2 rapid acetylator.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Plan B (Progestins)

Actos (Thiazolidinediones)

Amaryl (Sulfonylureas)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com